Trial Profile
A study of Telavancin in the treatment of Staphylococcus aureus bacteremia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Telavancin (Primary)
- Indications Staphylococcal infections
- Focus Adverse reactions; Therapeutic Use
- 18 Dec 2015 New trial record